Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 2281
116th Congress(2019-2020)
Easy MAT for Opioid Addiction Act
Active
Active
Passed House on Nov 17, 2020
Overview
Text
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 2281 (Reported-in-House)

Union Calendar No. 485

116th CONGRESS
2d Session
H. R. 2281

[Report No. 116–587, Part I]


To direct the Attorney General to amend certain regulations so that practitioners may administer not more than 3 days’ medication to a person at one time when administering narcotic drugs for the purpose of relieving acute withdrawal symptoms.

IN THE HOUSE OF REPRESENTATIVES

April 10, 2019

Mr. Ruiz introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

November 16, 2020

Additional sponsor: Mr. Walden

November 16, 2020

Reported from the Committee on Energy and Commerce with amendments

[Strike out all after the enacting clause and insert the part printed in italic]

November 16, 2020

Committee on the Judiciary discharged; committed to the Committee of the Whole House on the State of the Union and ordered to be printed

[For text of introduced bill, see copy of bill as introduced on April 10, 2019]

A BILL

To direct the Attorney General to amend certain regulations so that practitioners may administer not more than 3 days’ medication to a person at one time when administering narcotic drugs for the purpose of relieving acute withdrawal symptoms.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Easy Medication Access and Treatment for Opioid Addiction Act” or the “Easy MAT for Opioid Addiction Act”.

SEC. 2. Dispensation of narcotic drugs for the purpose of relieving acute withdrawal symptoms from opioid use disorder.

Not later than 180 days after the date of enactment of this Act, the Attorney General shall revise section 1306.07(b) of title 21, Code of Federal Regulations, so that practitioners, in accordance with applicable State, Federal, or local laws relating to controlled substances, are allowed to dispense not more than a three-day supply of narcotic drugs to one person or for one person’s use at one time for the purpose of initiating maintenance treatment or detoxification treatment (or both).

Amend the title so as to read: “A bill to direct the Attorney General to amend certain regulations so that practitioners may dispense not more than 3 days’ medication to a person at one time when administering narcotic drugs for the purpose of relieving acute withdrawal symptoms.”.

Union Calendar No. 485

116th CONGRESS
     2d Session
H. R. 2281
[Report No. 116–587, Part I]
A BILL
To direct the Attorney General to amend certain regulations so that practitioners may administer not more than 3 days’ medication to a person at one time when administering narcotic drugs for the purpose of relieving acute withdrawal symptoms.
November 16, 2020
Reported from the Committee on Energy and Commerce with amendments
November 16, 2020
Committee on the Judiciary discharged; committed to the Committee of the Whole House on the State of the Union and ordered to be printed